Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9233304 | 0.87 | SIGMAR1 (0.46) | MEN1KMT2A | |
| SCHEMBL820953 | 0.84 | TSHR (0.46) | TSHRPOLBMEN1KMT2AALDH1A1 | |
| SCHEMBL13626178 | 0.84 | TSHR (0.46) | TSHRPOLBMEN1KMT2AALDH1A1 | |
| SCHEMBL837629 | 0.83 | TSHR (0.44) | TSHRPOLBMEN1KMT2AALDH1A1 | |
| SCHEMBL14118736 | 0.81 | BCHE (0.46) | TSHRPOLBMEN1KMT2AALDH1A1 | |
| SCHEMBL17929078 | 0.81 | SMN1; SMN2 (0.46) | TSHRPOLBMEN1KMT2AALDH1A1 | |
| SCHEMBL104982 | 0.81 | TSHR (0.43) | TSHRPOLBMEN1KMT2AALDH1A1 | |
| SCHEMBL22587234 | 0.79 | TSHR (0.42) | TSHRPOLBMEN1KMT2AALDH1A1 | |
| SCHEMBL4785593 | 0.78 | TSHR (0.52) | TSHRPOLBMEN1KMT2AALDH1A1 | |
| SCHEMBL10697566 | 0.78 | TSHR (0.52) | TSHRPOLBMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2072083-B1 | Utilisation of 2.4'-dimethyl-propiophenon as an aroma | SYMRISE AG (DE) | 2012-02-15 | — | — | EP | claimed |
| EP-2072083-A1 | Utilisation of 2.4'-dimethyl-propiophenon as an aroma | Symrise GmbH & Co. KG (DE) | 2009-06-24 | — | — | EP | claimed |
| EP-1682230-A1 | 4,8-DIMETHYL-7-NONEN-2-ONE AND 4,8-DIMETHYLNONAN-2-ONE USED AS PERFUMES | Symrise GmbH & Co. KG (DE) | 2006-07-26 | — | — | EP | claimed |
| WO-2005004825-A1 | 4,8-DIMETHYL-7-NONEN-2-ONE AND 4,8-DIMETHYLNONAN-2-ONE USED AS PERFUMES | SYMRISE GMBH & CO. KG (DE) | 2005-01-20 | — | — | WO | claimed |
| EP-2072083-B1 | Utilisation of 2.4'-dimethyl-propiophenon as an aroma | SYMRISE AG (DE) | 2012-02-15 | — | — | EP | disclosed |
| US-20090162308-A1 | USE OF 2,4'-DIMETHYLPROPIOPHENONE AS A FRAGRANCE SUBSTANCE | SYMRISE GMBH & CO. KG (DE) | 2009-06-25 | — | — | US | disclosed |
| EP-2072083-A1 | Utilisation of 2.4'-dimethyl-propiophenon as an aroma | Symrise GmbH & Co. KG (DE) | 2009-06-24 | — | — | EP | disclosed |
| EP-1682230-A1 | 4,8-DIMETHYL-7-NONEN-2-ONE AND 4,8-DIMETHYLNONAN-2-ONE USED AS PERFUMES | Symrise GmbH & Co. KG (DE) | 2006-07-26 | — | — | EP | disclosed |
| WO-2005004825-A1 | 4,8-DIMETHYL-7-NONEN-2-ONE AND 4,8-DIMETHYLNONAN-2-ONE USED AS PERFUMES | SYMRISE GMBH & CO. KG (DE) | 2005-01-20 | — | — | WO | disclosed |
| EP-0977743-A1 | PROTEASE INHIBITORS | Smithkline Beecham (US) | 2000-02-09 | — | — | EP | disclosed |
| WO-1998049152-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-11-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090162308-A1 | USE OF 2,4'-DIMETHYLPROPIOPHENONE AS A FRAGRANCE SUBSTANCE | CYP1B1, CYP4A22, ROS1 | TSHR 4709/4885POLB 3044/4885MEN1 2673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.